Hims & Hers Health Inc - Class A Stock Prediction and Forecast [HIMS]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 18 Oct 2025, 03:47 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Hims & Hers Health Inc - Class A Stock Prediction and Forecast [HIMS]](https://i.ytimg.com/vi/-PFRL6RVkMI/hqdefault.jpg)
AI-generated source summary
Hims & Hers Health Inc - Class A (HIMS) is presented as a sell candidate with a score of -4.125, assessed on October 17, 2025. The stock has been rising in the broad and moderate upward trend. The system estimates potential changes of approximately 4.48% over the next three months, with possible returns ranging from -9.64% to 44.22%. A 12-month analysis projects a 60.65% change. The stock's performance could vary from 37.66% to 197.06% over the coming year with future prices varying between 68.53 and 147.87. The last daily update on Friday shows a close at $49.78, falling by -15.84% with increased volume signaling an early warning and risk is increasing. According to the analyst some resistance from the lines at 56.09 and 53.51. The chart shows a SELL signal based on MACD and BUY from Bollinger. Our system predicts that open trading will start trading with the open price undervalued and at 52.29.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
